Response

Affiliations

¹ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA (KN, CSF); Division of Gastroenterology, Massachusetts General Hospital, Boston, MA (ATC). kimmie_ng@dfci.harvard.edu.
² Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA (KN, CSF); Division of Gastroenterology, Massachusetts General Hospital, Boston, MA (ATC).

Comment

Kimmie Ng et al. J Natl Cancer Inst. 2015.

. 2015 Jun 4;107(8):djv150.

doi: 10.1093/jnci/djv150. Print 2015 Aug.

¹ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA (KN, CSF); Division of Gastroenterology, Massachusetts General Hospital, Boston, MA (ATC). kimmie_ng@dfci.harvard.edu.
² Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA (KN, CSF); Division of Gastroenterology, Massachusetts General Hospital, Boston, MA (ATC).

No abstract available

Comment on

Aspirin and COX-2 inhibitor use in patients with stage III colon cancer.
Ng K, Meyerhardt JA, Chan AT, Sato K, Chan JA, Niedzwiecki D, Saltz LB, Mayer RJ, Benson AB 3rd, Schaefer PL, Whittom R, Hantel A, Goldberg RM, Venook AP, Ogino S, Giovannucci EL, Fuchs CS. Ng K, et al. J Natl Cancer Inst. 2014 Nov 27;107(1):345. doi: 10.1093/jnci/dju345. Print 2015 Jan. J Natl Cancer Inst. 2014. PMID: 25432409 Free PMC article.
RE: Aspirin and COX-2 Inhibitor Use in Patients With Stage III Colon Cancer.
Lee M, Gibbs P. Lee M, et al. J Natl Cancer Inst. 2015 Jun 4;107(8):djv149. doi: 10.1093/jnci/djv149. Print 2015 Aug. J Natl Cancer Inst. 2015. PMID: 26048994 Free PMC article. No abstract available.

1. Baron JA, Cole BF, Sandler RS, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med. 2003;348(10):891–899. - PubMed
1. Sandler RS, Halabi S, Baron JA, et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med. 2003;348(10):883–890. - PubMed
1. Benamouzig R, Deyra J, Martin A, et al. Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial. Gastroenterology. 2003;125(2):328–336. - PubMed
1. Fuchs CS, Meyerhardt JA, Brady D, et al. Influence of regular aspirin use on survival for patients with stage III colon cancer: Findings from Intergroup trial CALGB 89803. J Clin Oncol. 2005;23(Suppl 16):Abstract 3530.
1. Chan AT, Ogino S, Fuchs CS. Aspirin use and survival after diagnosis of colorectal cancer. JAMA. 2009;302(6):649–658. - PMC - PubMed